FindTrial
Sign In

The effect of Vitamin D supplementation over mild to moderate asthma outcome in 6-14 years old children

The effect of Vitamin D supplementation over mild to moderate asthma outcome in 6-14 years old children

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110127784N1
Enrollment
80
Registered
2012-12-01
Start date
2011-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Asthma. Condition 2: Asthma. Condition 3: Asthma. Nonallergic asthma Mixed asthma Predominantly allergic asthma

Interventions

Intervention 1: intervention: Vitamin D supplementation 500 U per day for 3 months + spray Fluticasone 100-500 microgram per day. Intervention 2: control: spray Fluticasone 100-500 microgram per day
Treatment - Drugs
intervention: Vitamin D supplementation 500 U per day for 3 months + spray Fluticasone 100-500 microgram per day
control: spray Fluticasone 100-500 microgram per day as standard treatment of asthma

Sponsors

Immunology, Asthma and Allergy Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: inclusion criteria:1- Patients with mild to moderate asthma diagnosed by physician2 - Patients who are less than 3 months of treatment over the past 3 - patients between 6-14 years old; Exclusion criteria: 1 - Patients with severe asthma 2 - patients treated with immunotherapy or anti IgE 3 - Patients with chronic diseases like cardiovascular disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
S-IgE. Timepoint: before and 4-6 months after intervention. Method of measurement: RIDA.—

Primary

MeasureTime frame
FEV1. Timepoint: before and 4-6 months after intervention. Method of measurement: spirometry.;FEV1/FVC. Timepoint: before and 4-6 months after intervention. Method of measurement: spirometry.;Quality of life. Timepoint: before and 4-6 months after intervention. Method of measurement: Questionnaire.;Asthma control. Timepoint: before and 4-6 months after intervention. Method of measurement: Questionnaire.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Darabi MD

Allergy and clinical immunology unit,Centeral Medical Center

arabibh@razi.tums.ac.ir009821:66920981-3

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026